These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1639470)

  • 1. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.
    Yang L; Ma Y; Schoenfeld R; Griffiths M; Eichwald E; Araneo B; Weis JJ
    Infect Immun; 1992 Aug; 60(8):3033-41. PubMed ID: 1639470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.
    Schoenfeld R; Araneo B; Ma Y; Yang LM; Weis JJ
    Infect Immun; 1992 Feb; 60(2):455-64. PubMed ID: 1730476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
    Yang L; Weis JH; Eichwald E; Kolbert CP; Persing DH; Weis JJ
    Infect Immun; 1994 Feb; 62(2):492-500. PubMed ID: 8300208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.
    Zeidner N; Mbow ML; Dolan M; Massung R; Baca E; Piesman J
    Infect Immun; 1997 Aug; 65(8):3100-6. PubMed ID: 9234760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.
    Ma Y; Seiler KP; Eichwald EJ; Weis JH; Teuscher C; Weis JJ
    Infect Immun; 1998 Jan; 66(1):161-8. PubMed ID: 9423853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
    Ma Y; Weis JJ
    Infect Immun; 1993 Sep; 61(9):3843-53. PubMed ID: 8359905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DBA/1 strain is a novel mouse model for experimental Borrelia burgdorferi infection.
    Campfield BT; Nolder CL; Davis A; Hirsch R; Nowalk AJ
    Clin Vaccine Immunol; 2012 Oct; 19(10):1567-73. PubMed ID: 22855391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis.
    Schaible UE; Kramer MD; Wallich R; Tran T; Simon MM
    Eur J Immunol; 1991 Oct; 21(10):2397-405. PubMed ID: 1915553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi.
    Ganapamo F; Dennis VA; Philipp MT
    Infect Immun; 2000 Dec; 68(12):7162-5. PubMed ID: 11083848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.
    Seiler KP; Vavrin Z; Eichwald E; Hibbs JB; Weis JJ
    Infect Immun; 1995 Oct; 63(10):3886-95. PubMed ID: 7558296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection.
    Belperron AA; Dailey CM; Booth CJ; Bockenstedt LK
    Infect Immun; 2007 Jul; 75(7):3354-60. PubMed ID: 17470546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.
    Tai KF; Ma Y; Weis JJ
    Infect Immun; 1994 Feb; 62(2):520-8. PubMed ID: 8300210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment.
    Iliopoulou BP; Alroy J; Huber BT
    Arthritis Rheum; 2008 Dec; 58(12):3892-901. PubMed ID: 19035513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
    Anguita J; Persing DH; Rincon M; Barthold SW; Fikrig E
    J Clin Invest; 1996 Feb; 97(4):1028-34. PubMed ID: 8613525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short report: Association of macrophage inflammatory response and cell death after in vitro Borrelia burgdorferi infection with arthritis resistance.
    Glickstein LJ; Coburn JL
    Am J Trop Med Hyg; 2006 Nov; 75(5):964-7. PubMed ID: 17123997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.
    Brown CR; Reiner SL
    Infect Immun; 1998 Nov; 66(11):5208-14. PubMed ID: 9784524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi.
    Potter MR; Rittling SR; Denhardt DT; Roper RJ; Weis JH; Teuscher C; Weis JJ
    Infect Immun; 2002 Mar; 70(3):1372-81. PubMed ID: 11854223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies.
    Honarvar N; Schaible UE; Galanos C; Wallich R; Simon MM
    Immunology; 1994 Jul; 82(3):389-96. PubMed ID: 7959873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.
    Ekerfelt C; Andersson M; Olausson A; Bergström S; Hultman P
    Clin Exp Immunol; 2007 Oct; 150(1):189-97. PubMed ID: 17672870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
    Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
    J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.